These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14679954)

  • 1. New horizons in diabetes treatment.
    Marino MT
    Diabetes Self Manag; 2003; 20(5):67-8, 70. PubMed ID: 14679954
    [No Abstract]   [Full Text] [Related]  

  • 2. Oradian, a new oral antidiabetic drug.
    Bretán M; Balázsi I
    Ther Hung; 1965; 13(2):59-61. PubMed ID: 5320879
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of diabetes in the aged with the oral antidiabetic drug Redul].
    Jansen W
    Med Monatsschr; 1965 Jun; 19(6):280-1. PubMed ID: 5318643
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of glycodiazine--a new oral hypoglycemic drug.
    Eisenberg S; Cohen AM
    Isr J Med Sci; 1966; 2(6):768-73. PubMed ID: 5334155
    [No Abstract]   [Full Text] [Related]  

  • 5. Pilot evaluation of BL-H381 in treatment of diabetes mellitus.
    Cohen A; Beber C; Leb S; DeFelice EA
    Curr Ther Res Clin Exp; 1966 Oct; 8(10):472-8. PubMed ID: 4961023
    [No Abstract]   [Full Text] [Related]  

  • 6. The UGDP and the FDA audit.
    Am Fam Physician; 1979 Jul; 20(1):67. PubMed ID: 377929
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
    Isaacsohn JL; Troendle AJ; Orloff DG
    Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of tolazamide in the treatment of diabetes mellitus.
    Beidleman B; Prevatt AL; Palmer RC
    J Fla Med Assoc; 1966 Mar; 53(3):191-3. PubMed ID: 5323398
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech on the rise: diabetes.
    Leewe J
    Biotechnol J; 2009 Feb; 4(2):172-3. PubMed ID: 19226551
    [No Abstract]   [Full Text] [Related]  

  • 10. More from PHARMAC on long-acting insulin analogues: insulin glargine now funded.
    Moodie P
    N Z Med J; 2006 Jun; 119(1236):U2040. PubMed ID: 16807582
    [No Abstract]   [Full Text] [Related]  

  • 11. American Diabetes Association--66th scientific sessions. Updates on drug treatments. 9-13 June 2006, Washington, DC, USA.
    Jago C
    IDrugs; 2006 Aug; 9(8):542-4. PubMed ID: 16871460
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hypoglycemic agents on patients with diabetes.
    Yudkin JS; Smits P
    Circulation; 1997 Nov; 96(10):3797-8. PubMed ID: 9396501
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experiences with the Oradian therapy of diabetes.
    Csapó G; Szücs Z
    Ther Hung; 1965; 13(3):119-21. PubMed ID: 5322239
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent.
    Choudhry AS; Gomez E; McKendry JB
    Appl Ther; 1970 May; 12(5):28-9. PubMed ID: 4912481
    [No Abstract]   [Full Text] [Related]  

  • 15. [Novo Nordisk introduces a new basic insulin for marketing].
    Krankenpfl J; 2004; 42(5-6):168-9. PubMed ID: 15527230
    [No Abstract]   [Full Text] [Related]  

  • 16. Tough to treat. Diabetes and heart failure.
    Gottlieb SH
    Diabetes Forecast; 2005 Sep; 58(9):35-7. PubMed ID: 16187431
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparative study of older and newer types of peroral antidiabetics].
    Dobesová L; Sieberová R
    Vnitr Lek; 1967 Apr; 13(4):344-7. PubMed ID: 4860055
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials for treatment of NODAT: time to collaborate.
    Sharif A; de Vries AP; Porrini E; Hecking M; Saemann M;
    Transplantation; 2012 Aug; 94(4):e23-4; author reply e24-5. PubMed ID: 22914113
    [No Abstract]   [Full Text] [Related]  

  • 20. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
    Misbin RI
    Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.